BridgeBio Oncology Therapeutics, Inc. BBOT 深 沪
等待开盘 03-26 09:30:00 美东时间
9.25
+0.530
+6.08%
华盛通- 最 高9.39
- 今 开8.86
- 成交量 9.78万股
- 最 低 8.86
- 昨 收 8.72
- 总市值 7.40亿
- 52周最高 14.87
- 市盈率 静 --
- 换手率 0.12%
- 52周最低 8.50
- 委 比 -94.55%
- 总股本 8003.28万
- 历史最高 14.87
- 量 比 0.73
- 振 幅 6.08%
- 历史最低 8.50
- 每 手 1
- 风险率 1.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元
03-09 11:47
HC Wainwright & Co. Maintains Buy on BridgeBio Oncology, Raises Price Target to $29
HC Wainwright & Co. analyst Robert Burns maintains BridgeBio Oncology (NASDAQ:BBOT) with a Buy and raises the price target from $27 to $29.
03-06 20:13
BridgeBio Oncology Q4 EPS $(0.49) Beats $(0.56) Estimate
BridgeBio Oncology (NASDAQ:BBOT) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.56) by 13.12 percent.
03-06 05:10
美股大行评级 | 杜邦、吉利德科学、Cloudflare、Saia获多家大行上调目标价；Datadog、Robinhood、Klaviyo、Lyft等遭多家大行下调目标价
今日重点评级关注：Benchmark：维持Klaviyo"买入"评级，目标价从30美元升至33美元；富国银行：维持Cloudflare"超配"评级，目标价从265美元升至270美元
02-12 14:02
Stifel Initiates Coverage On BridgeBio Oncology with Buy Rating, Announces Price Target of $23
Stifel analyst Laura Prendergast initiates coverage on BridgeBio Oncology (NASDAQ:BBOT) with a Buy rating and announces Price Target of $23.
02-11 23:06
美股大行评级 | 瑞穗上调英伟达、谷歌、美光科技、SanDisk多家科技股目标价；中金首予诺和诺德"跑赢大市"评级，目标价73.5美元
今日重点评级关注：Needham：维持Cartesian Therapeutics"买入"评级，目标价从40美元升至42美元；Piper Sandler：维持Acrivon Therapeutics"超配"评级，目标价从6美元升至8美元
01-12 14:09
Raymond James Initiates Coverage On BridgeBio Oncology with Outperform Rating, Announces Price Target of $24
Raymond James analyst Sean McCutcheon initiates coverage on BridgeBio Oncology (NASDAQ:BBOT) with a Outperform rating and announces Price Target of $24.
01-09 22:09
美股大行评级 | 高盛上调梅西百货目标价至22美元！ 摩根大通上调美国铝业公司目标价至45美元
今日重点评级关注：Stifel：维持X4 Pharmaceuticals"买入"评级，目标价从7.5美元升至10美元；花旗：维持UP Fintech Holding"买入"评级，目标价从17.4美元升至17.5美元
2025-12-08 08:34
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Praxis Precision Medicine (NASDAQ:PRAX) shares moved upwards by 33.6% ...
2025-12-06 01:05
Morgan Stanley Initiates Coverage On BridgeBio Oncology with Overweight Rating, Announces Price Target of $20
Morgan Stanley analyst Sean Laaman initiates coverage on BridgeBio Oncology (NASDAQ:BBOT) with a Overweight rating and announces Price Target of $20.
2025-12-05 23:22
